Enzo Biochem, Inc. ENZ NYSE

Enzo Biochem, Inc. (ENZ) reported total assets of $63.52M and total liabilities of $20.12M for quarter ending 2025-04-30, resulting in total equity of $43.4M.

The company held $36.69M in cash and short-term investments. Total debt stood at $3M, with net debt of $-33.69M. The Debt-to-Equity (D/E) ratio was 0.07 (conservative).

Current ratio is 2.84, indicating strong short-term liquidity.

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (39/100) — Total assets $63.52M and equity $43.4M support the company's competitive scale

Overall SharesGrow Score: 36/100 with 0/7 criteria passed.